Physician profile
Barbra R Johnson
NPI 1922140805
$2,779.98
in general payments reported to CMS, 2019-2025
17 companies · $529 in 2025
The $529 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2021: $274 · 2022: $338 · 2023: $358 · 2024: $1,166 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $550.31 | 2024 | Optilight |
| Johnson & Johnson Vision Care, INC. | $373.19 | 2019-2025 | Acuvue |
| Allergan, INC. | $244.73 | 2021-2022 | |
| Lkc Technologies, INC. | $223.13 | 2024 | |
| Oyster Point Pharma, INC. | $169.56 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $159.85 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $158.50 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $140.28 | 2024 | |
| Kala Pharmaceuticals, INC. | $120.45 | 2021 | |
| Alcon Vision LLC | $119.63 | 2024 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $103.32 | 2024 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Sight Sciences, INC. | $99.38 | 2025 | Omni Surgical System, Tearcare System |
| Horizon Therapeutics Plc | $68.56 | 2023 | Tepezza |
| Glaukos Corporation | $63.36 | 2025 | Idosetr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $43.48 | 2025 | Synergeyes Contact Lens, Misight Contact Lens |
| Carl Zeiss Meditec USA, INC. | $42.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbra Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.